Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Total Liabilities (2023 - 2025)

Historic Total Liabilities for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $42.3 million.

  • CG Oncology's Total Liabilities rose 16921.85% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.3 million, marking a year-over-year increase of 16921.85%. This contributed to the annual value of $21.4 million for FY2024, which is 4761.22% up from last year.
  • Latest data reveals that CG Oncology reported Total Liabilities of $42.3 million as of Q3 2025, which was up 16921.85% from $31.1 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Total Liabilities ranged from a high of $42.3 million in Q3 2025 and a low of $10.2 million during Q1 2024
  • For the 3-year period, CG Oncology's Total Liabilities averaged around $21.3 million, with its median value being $18.6 million (2024).
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 4761.22% in 2024, then skyrocketed by 16921.85% in 2025.
  • CG Oncology's Total Liabilities (Quarter) stood at $14.5 million in 2023, then skyrocketed by 47.61% to $21.4 million in 2024, then skyrocketed by 97.34% to $42.3 million in 2025.
  • Its Total Liabilities was $42.3 million in Q3 2025, compared to $31.1 million in Q2 2025 and $23.4 million in Q1 2025.